TR200003515T2 - İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı - Google Patents

İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı

Info

Publication number
TR200003515T2
TR200003515T2 TR2000/03515T TR200003515T TR200003515T2 TR 200003515 T2 TR200003515 T2 TR 200003515T2 TR 2000/03515 T TR2000/03515 T TR 2000/03515T TR 200003515 T TR200003515 T TR 200003515T TR 200003515 T2 TR200003515 T2 TR 200003515T2
Authority
TR
Turkey
Prior art keywords
medicines
manufacture
relates
substituted
substituted indolinone
Prior art date
Application number
TR2000/03515T
Other languages
English (en)
Inventor
Heckel Armin
Walter Rainer
Grell Wolfgang
C.A. Van Meel Jacobus
Redemann Norbert
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of TR200003515T2 publication Critical patent/TR200003515T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Isbu bulus R1 ila R5'in ve X'in 1 sayili istemde tanimlandigi gibi oldugu genel formül (I)'e ait ikame edilmis indolinler, bunlarin izomerleri ve bunlarin tuzlari, özellikle de degerli farmakolojik özellikler sergileyen, özellikle de farkli kinazlar ve siklin/CDK kompleksleri üzerinde ve farkli tümör hücrelerinin çogalmasi üzerinde baskilayici olan, fizyolojik olarak uygun olan tuzlari ile ilgilidir. Bulus ayni zamanda bu bilesikleri içeren ilaçlari, bunlarin kullanimi ve bunlarin üretimine yönelik bir yöntemle ilgilidir.
TR2000/03515T 1998-06-04 1999-05-28 İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı TR200003515T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19824922A DE19824922A1 (de) 1998-06-04 1998-06-04 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
TR200003515T2 true TR200003515T2 (tr) 2001-06-21

Family

ID=7869856

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03515T TR200003515T2 (tr) 1998-06-04 1999-05-28 İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı

Country Status (23)

Country Link
EP (1) EP1100779A1 (tr)
JP (1) JP2002516906A (tr)
KR (1) KR20010043973A (tr)
CN (1) CN1303374A (tr)
AU (1) AU764782B2 (tr)
BG (1) BG104938A (tr)
BR (1) BR9910898A (tr)
CA (1) CA2328291A1 (tr)
CO (1) CO5050294A1 (tr)
DE (1) DE19824922A1 (tr)
EA (1) EA003514B1 (tr)
EE (1) EE200000723A (tr)
HR (1) HRP20000831A2 (tr)
HU (1) HUP0102210A3 (tr)
ID (1) ID27035A (tr)
IL (1) IL138702A0 (tr)
NO (1) NO20006138L (tr)
PL (1) PL344467A1 (tr)
SK (1) SK18222000A3 (tr)
TR (1) TR200003515T2 (tr)
WO (1) WO1999062882A1 (tr)
YU (1) YU73900A (tr)
ZA (1) ZA200005435B (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816624A1 (de) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
UA75054C2 (uk) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
US6762180B1 (en) 1999-10-13 2004-07-13 Boehringer Ingelheim Pharma Kg Substituted indolines which inhibit receptor tyrosine kinases
WO2002020513A1 (en) * 2000-09-01 2002-03-14 Glaxo Group Limited Oxindole derivatives
AU2001288374A1 (en) 2000-09-01 2002-03-22 Glaxo Group Limited Substituted oxindole derivatives as tyrosine kinase inhibitors
DE10117204A1 (de) 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
ES2274075T3 (es) 2001-06-29 2007-05-16 Ab Science Utilizacion de inhibidores de c-kit para tratar enfermedades inflamatorias intestinales (eii).
ES2266553T3 (es) 2001-06-29 2007-03-01 Ab Science Utilizacion de derivados de la n-fenil-2-pirimidina-amina para tratar las enfermedades inflamatorias.
EP1401413B1 (en) 2001-06-29 2006-11-22 AB Science Use of tyrosine kinase inhibitions for treating allergic diseases
ATE401079T1 (de) * 2001-06-29 2008-08-15 Ab Science Die verwendung von c-kithemmern zur behandlung von autoimmunerkrankungen
DE60223063T2 (de) 2001-06-29 2008-07-17 Ab Science C-kit inhibitoren
CA2461812C (en) 2001-09-27 2011-09-20 Allergan, Inc. 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
DE102004012070A1 (de) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
PE20060777A1 (es) * 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
SG177128A1 (en) * 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
CN101735071A (zh) * 2009-12-04 2010-06-16 大连凯飞精细化工有限公司 一种生产4-n,n-二甲胺基甲基苯胺的方法
CN103102352B (zh) * 2011-11-15 2015-08-12 山东亨利医药科技有限责任公司 酪氨酸激酶抑制剂吲哚满酮衍生物
CN103130775B (zh) * 2011-11-22 2015-09-30 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的吲哚满酮衍生物
GB201208775D0 (en) * 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds
CN103848814B (zh) * 2012-12-06 2016-08-17 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的取代吲哚满酮衍生物
US20240150368A1 (en) * 2022-09-02 2024-05-09 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE838623A (fr) * 1976-02-16 1976-06-16 Derives de 3-hydroxymethylene-2-indolinone et procede pour leur production
US4145422A (en) * 1977-09-06 1979-03-20 Abbott Laboratories Aminomethylene oxindoles
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
CA2264220A1 (en) * 1996-08-23 1998-02-26 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
JP2002516906A (ja) 2002-06-11
DE19824922A1 (de) 1999-12-09
CA2328291A1 (en) 1999-12-09
HUP0102210A2 (hu) 2001-11-28
CO5050294A1 (es) 2001-06-27
AU4370799A (en) 1999-12-20
IL138702A0 (en) 2001-10-31
EE200000723A (et) 2002-04-15
BG104938A (en) 2001-06-29
PL344467A1 (en) 2001-11-05
WO1999062882A1 (de) 1999-12-09
AU764782B2 (en) 2003-08-28
HRP20000831A2 (en) 2001-12-31
HUP0102210A3 (en) 2002-12-28
CN1303374A (zh) 2001-07-11
EA003514B1 (ru) 2003-06-26
NO20006138L (no) 2001-02-01
EP1100779A1 (de) 2001-05-23
ID27035A (id) 2001-02-22
ZA200005435B (en) 2002-01-07
NO20006138D0 (no) 2000-12-01
YU73900A (sh) 2003-04-30
KR20010043973A (ko) 2001-05-25
SK18222000A3 (sk) 2001-08-06
BR9910898A (pt) 2001-02-13
EA200100001A1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
TR200003515T2 (tr) İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı
MY122357A (en) Indolinones having kinase inhibitory activity
YU26602A (sh) Indolinon supstituisan na poziciji 6, njegovo dobijanje i njegova primena kao leka
EE200100184A (et) Uudsed asendatud indolinoonid inhibeeriva toimegamitmesugustele kinaasidele ja tsükliin/CDK kompleksidele
AR025389A1 (es) Indolinonas sustituidas, su preparacion y su empleo como medicamentos
PL346840A1 (en) Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
HUP0102512A2 (hu) Áthidalt indeno-pirrolo-karbazol-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
AU4368799A (en) Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
HK1042479A1 (en) 2-Amino-6-anilino-purines and their use as medicaments.
ATE197038T1 (de) N-aroyl-glycin-hydroxamsäure-derivate und verwandte verbindungen
WO2001027080A3 (de) In 5-stellung substituierte indolinone und ihre verwendung als kinase und cyclin-cdk-komplexe inhibitoren
EA200301005A1 (ru) Замещенные в положении 6 индолиноны и их применение в качестве ингибиторов киназ
RS20050047A (en) Indoline derivatives substituted in position 6,production and use thereof as medicaments
TR200100286T2 (tr) (1H)-Benzo[C]kuinolizin-3-on türevlerinin sentezi için proses.
TR200101083T2 (tr) (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.
CA2239282A1 (en) Fused isoindolones as inhibitors of protein kinase c
ATE298003T1 (de) Ein tumorsuppressor namens ts10q23.3
UY26308A1 (es) Nuevas indolinonas sustituidas, su preparación y su empleo como medicamentos
CN110483531A (zh) 一种水溶性卟啉烯衍生物、制备方法、抗肿瘤药物和应用
Al-Humain et al. Genotoxic Effects of New Azoloazine Derivatives with Antitumor Activity in MCF-7 Tumor Cell Culture
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
UY26180A1 (es) Nuevas indolinonas sustituidas, su preparación y su empleo como medicamentos
ECSP003491A (es) Nuevas indolinonas sustituidas, su preparacion y su empleo como medicamentos
EE200100062A (et) Uued 2,3,3a,4,9,9a-heksahüdro-8-hydroxy-1H-bens(f)indoolid, meetodid nende valmistamiseks ja nende kasutamine ravimitena
Zhao et al. BTK-PROTAC targeting BTK degradation as a new weapon for the treatment of B-cell lymphomas